Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-31

FDA Approved: SUMATRIPTAN — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approval of a generic Sumatriptan product (Original Application) by Rising Pharma Holdings, Inc. for acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan (Sumatriptan)

Snippet

ORIG AP for SUMATRIPTAN (SUMATRIPTAN)